Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-05-13 7:21 pm Purchase | 13D | T2 BIOSYSTEMS INC PAR $0.0 TTOO | CR Group L.P. | 10,677,973 69.500% | 1,824,800 (+20.61%) | View |
| 2024-05-07 7:46 pm Purchase | 13D | T2 BIOSYSTEMS INC PAR $0.0 TTOO | CR Group L.P. | 8,853,173 65.400% | 4,748,335 (+115.68%) | View |
| 2024-04-19 4:31 pm Purchase | 13D | T2 BIOSYSTEMS INC PAR $0.0 TTOO | CR Group L.P. | 4,104,838 46.680% | 4,104,838 (New Position) | View |
| 2024-03-15 5:00 pm Purchase | 13G | AVINGER INC 2023 AVGR | CR Group L.P. | 150,545 9.900% | 150,545 (New Position) | View |
| 2023-08-14 3:22 pm Purchase | 13G | AVINGER INC 2023 AVGR | CR Group L.P. | 2,684,160 19.900% | 2,684,160 (New Position) | View |
| 2023-07-13 3:58 pm Purchase | 13G | T2 BIOSYSTEMS INC PAR $0.0 TTOO | CR Group L.P. | 72,503,592 19.900% | 72,503,592 (New Position) | View |
| 2021-01-06 4:15 pm Sale | 13G | Assertio Holdings Inc. ASRT | CR Group L.P. | 291,148 0.300% | -6,000,000 (-95.37%) | View |
| 2020-12-30 4:19 pm Sale | 13G | Assertio Holdings Inc. ASRT | CR Group L.P. | 6,291,148 5.600% | -11,267,185 (-64.17%) | View |
| 2020-06-09 12:04 pm Unchanged | 13D | TearLab Corp TEAR | CR Group L.P. | 11,850,131 48.500% | 0 (Unchanged) | View |
| 2020-05-28 4:05 pm Purchase | 13G | Assertio Holdings Inc. ASRT | CR Group L.P. | 17,558,333 15.800% | 17,558,333 (New Position) | View |
| 2020-05-22 4:07 pm Sale | 13D | Zyla Life Sciences ZCOR | CR Group L.P. | 0 0.000% | -7,023,333 (Position Closed) | View |
| 2020-05-21 12:01 pm Purchase | 13D | TearLab Corp TEAR | CR Group L.P. | 11,850,131 48.500% | 11,850,131 (New Position) | View |
| 2020-03-25 8:53 pm Unchanged | 13D | Zyla Life Sciences ZCOR | CR Group L.P. | 7,023,333 58.700% | 0 (Unchanged) | View |
| 2020-02-13 3:42 pm Purchase | 13G | VIVEVE MED INC PAR $ VIVE | CR Group L.P. | 6,986,473 67.200% | 6,986,473 (New Position) | View |
| 2020-02-13 3:39 pm Purchase | 13G | AVINGER INC 2023 AVGR | CR Group L.P. | 2,090,869 16.800% | 2,090,869 (New Position) | View |